Kareem Essam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kareem Essam has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah S. Abdelsattar
Affiliations Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America, Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America
2 shared publications - Ayman El-Shibiny
Center for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza, Egypt
2 shared publications Salsabil Makky
2 shared publicationsAalaa Eid
1 shared publicationAbdallah S. Abdelsattar
1 shared publicationAly Fahmy Mohamed
The Holding Company for production of vaccines a, sera and drugs (VACSERA), Egypt
1 shared publication
Latest Publications
- Open Access
- 29 November 2022
- Published by Elsevier in Results in Chemistry
- Vol. 5
Characterization of the biosynthesized Syzygium aromaticum-mediated silver nanoparticles and its antibacterial and antibiofilm activity in combination with bacteriophage
- 29 November 2022
- Published by Elsevier in Results in Chemistry
- Vol. 5
Open AccessCharacterization of the biosynthesized Syzygium aromaticum-mediated silver nanoparticles and its antibacterial and antibiofilm activity in combination with bacteriophage
- Open Access
- 12 September 2022
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 20 (1) , 133-16
Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model
- 12 September 2022
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 20 (1) , 133-16
Open AccessBacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model
- 3 June 2022
- Published by Taylor & Francis in Inorganic and Nano-Metal Chemistry
- Vol. 53 (6) , 549-559
The antibacterial and biofilm inhibition activity of encapsulated silver nanoparticles in emulsions and its synergistic effect with E. coli bacteriophage
The paper investigates the efficiency of phage-nano combinational therapy in treating planktonic and biofilm bacteria. Silver nanoparticles (AgNPs) were synthesized by olive oil as a coating emulation and characterized. Then, the antibacterial activity, biofilm inhibition, and the compatibility of phage ZCEC5 with AgNPs were evaluated. The results revealed that AgNPs were effective against a wide range of bacteria including Enterobacter spp., Listeria monocytogenes, Klebsiella pneumoniae, Salmonella Enteritidis, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus sciuri, with a minimum inhibitory concentration (MIC) ranging from 0.6 to 3.15% and a minimum bactericidal concentration (MBC) ranged from 3.15 to 12.5%. As a model bacteria, E. coli O157:H7 was tested against the formulated AgNPs alone, and in combination with bacteriophage ZCEC5. While the MIC and MBC for E. coli treated with the AgNPs only were 1.1% and 3.15%, respectively, when combined with phage ZCEC5 (∼108 PFU/mL), the MIC and MBC were reduced to be 0.13% and 0.25%, respectively. Therefore, this paperwork introduces an antibacterial AgNPs against a wide spectrum of Gram-positive and Gram-negative bacteria, along with a novel combinational therapy of AgNPs and bacteriophage.
- 3 June 2022
- Published by Taylor & Francis in Inorganic and Nano-Metal Chemistry
- Vol. 53 (6) , 549-559
The antibacterial and biofilm inhibition activity of encapsulated silver nanoparticles in emulsions and its synergistic effect with E. coli bacteriophage
The paper investigates the efficiency of phage-nano combinational therapy in treating planktonic and biofilm bacteria. Silver nanoparticles (AgNPs) were synthesized by olive oil as a coating emulation and characterized. Then, the antibacterial activity, biofilm inhibition, and the compatibility of phage ZCEC5 with AgNPs were evaluated. The results revealed that AgNPs were effective against a wide range of bacteria including Enterobacter spp., Listeria monocytogenes, Klebsiella pneumoniae, Salmonella Enteritidis, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus sciuri, with a minimum inhibitory concentration (MIC) ranging from 0.6 to 3.15% and a minimum bactericidal concentration (MBC) ranged from 3.15 to 12.5%. As a model bacteria, E. coli O157:H7 was tested against the formulated AgNPs alone, and in combination with bacteriophage ZCEC5. While the MIC and MBC for E. coli treated with the AgNPs only were 1.1% and 3.15%, respectively, when combined with phage ZCEC5 (∼108 PFU/mL), the MIC and MBC were reduced to be 0.13% and 0.25%, respectively. Therefore, this paperwork introduces an antibacterial AgNPs against a wide spectrum of Gram-positive and Gram-negative bacteria, along with a novel combinational therapy of AgNPs and bacteriophage.
- Open Access
- 29 June 2020
- Published by Juniper Publishers in Journal of Forensic Sciences & Criminal Investigation
- Vol. 14 (2) , 0016-0025
Role of DNA in Paternity Testing
Egyptian society suffers from increasing in the number of divorce cases which leads to different problems. One of them is the children’s street that is a result of paternity issues. Paternity cases are caused due to huge problems between married couples because women may be entering a sexual partner in her life so the child will be not the son of her husband. This study discusses the techniques that are used in paternity cases in order to detect the biological father and prove which technique is more accurate compared to other techniques. Blood groups were the first approach that was used to detect whether the case is inclusion or exclusion. The most common and accurate technique is a short tandem repeat. This technique depends on 16 short tandem repeat loci founded on the chromosomes. It also depends on the length of each locus. This study discusses 6 samples concerned with 2 paternity cases while in one case concerned father, mother and two children.
- 29 June 2020
- Published by Juniper Publishers in Journal of Forensic Sciences & Criminal Investigation
- Vol. 14 (2) , 0016-0025
Open AccessRole of DNA in Paternity Testing
Egyptian society suffers from increasing in the number of divorce cases which leads to different problems. One of them is the children’s street that is a result of paternity issues. Paternity cases are caused due to huge problems between married couples because women may be entering a sexual partner in her life so the child will be not the son of her husband. This study discusses the techniques that are used in paternity cases in order to detect the biological father and prove which technique is more accurate compared to other techniques. Blood groups were the first approach that was used to detect whether the case is inclusion or exclusion. The most common and accurate technique is a short tandem repeat. This technique depends on 16 short tandem repeat loci founded on the chromosomes. It also depends on the length of each locus. This study discusses 6 samples concerned with 2 paternity cases while in one case concerned father, mother and two children.
- Open Access
- 3 August 2018
- Published by Juniper Publishers in International Journal of Pulmonary & Respiratory Sciences
- Vol. 3 (4) , 1-8
In Vitro Preparation of H2O2 Inactivated Rabies Vaccine and Related Immunogenicity
The aim of the present work is to produce local H2O2 inactivated vaccine and monitor its quality to the currently available in the Egyptian market. Data revealed that H2O2 could inactivate rabies virus within 3 hrs. Produced vaccine potency was evaluated using mice inoculation assay indicating that the ED50 of test vaccine was >2.5 IU according to the WHO regulation. Immune response was monitored on both cellular and humoral level revealing that anti rabies IgG was increasing relative to time and the same to IFN-γ and IL-5 IFN of local vaccine was significantly elevated than that in case of H2O2 prepared one.
- 3 August 2018
- Published by Juniper Publishers in International Journal of Pulmonary & Respiratory Sciences
- Vol. 3 (4) , 1-8
Open AccessIn Vitro Preparation of H2O2 Inactivated Rabies Vaccine and Related Immunogenicity
The aim of the present work is to produce local H2O2 inactivated vaccine and monitor its quality to the currently available in the Egyptian market. Data revealed that H2O2 could inactivate rabies virus within 3 hrs. Produced vaccine potency was evaluated using mice inoculation assay indicating that the ED50 of test vaccine was >2.5 IU according to the WHO regulation. Immune response was monitored on both cellular and humoral level revealing that anti rabies IgG was increasing relative to time and the same to IFN-γ and IL-5 IFN of local vaccine was significantly elevated than that in case of H2O2 prepared one.